Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	16.24	49.54	42.61
Graham Fair Price	-11.97	38.81	44.09
PEG	2510.57	-1.72	0.07
Price/Book	23.45	5.58	4.52
Price/Cash Flow	366.00	-52.96	11.37
Prices/Earnings	55.53	37.69	24.23
Price/Sales	22.49	15.20	12.41
Price/FCF	366.00	-52.96	11.37
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.81	0.55	0.56
Operating Margin	5.47	0.25	0.24
ROA	-25.40	< 0.005	< 0.005
ROE	0.05	0.04	-20.63
ROIC	0.02	0.02	-7.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	0.09	-33.20
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.09	0.04	-59.63
EPS QOQ	3.67	-0.22	-94.04
FCF QOQ	70.69	-1.26	-98.22
Revenue QOQ	0.02	-0.02	-12.52
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	484.31	551.62	13.90
Inventory Turnover	290000000.00	0.00	inf
Debt/Capitalization	0.68	0.70	3.18
Quick Ratio	1.04	1.04	0.89
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	43.04	42.53	-1.19
Cash	124.16	128.87	3.79
Capex	-0.99	-0.81	17.88
Free Cash Flow	17.12	-4.48	-73.82
Revenue	15.68	15.61	-0.42
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.05	1.06	1.44
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.35	8.70	18.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating